U.S. Media Stock News

Boise Cascade Company ( NYSE:BCC ) defied analyst predictions to release its quarterly results, which were ahead of...

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Last week saw the newest quarterly earnings release from Hess Midstream LP ( NYSE:HESM ), an important milestone in the...

CoStar Group, Inc. ( NASDAQ:CSGP ) shareholders (or potential shareholders) will be happy to see that the President...

Last week's profit announcement from MediaAlpha, Inc. ( NYSE:MAX ) was underwhelming for investors, despite headline...

As you might know, Labcorp Holdings Inc. ( NYSE:LH ) recently reported its first-quarter numbers. The result was...

The Cheesecake Factory Incorporated ( NASDAQ:CAKE ) shareholders are probably feeling a little disappointed, since its...

We'd be surprised if Bank of Hawaii Corporation ( NYSE:BOH ) shareholders haven't noticed that the Independent...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Key context for Synopsys after recent performance shift Synopsys (SNPS) has drawn fresh attention after a strong recent price move, with the stock up about 27% over the past month and roughly 23% in the past 3 months. That performance sits against an already positive backdrop, with total returns of about 5% over the past year, 36% across 3 years, and 121% over 5 years, prompting closer scrutiny of what investors are currently paying for the stock. See our latest analysis for Synopsys. The...

The Toro Company recently reported past first-quarter fiscal 2026 results that exceeded analyst expectations and raised its full-year guidance, powered by strong professional segment performance and contributions from its Tornado Infrastructure Equipment acquisition. The company also underscored continued investment in innovation and operational excellence, suggesting its professional equipment and infrastructure offerings are becoming increasingly important within its overall business...

What recent performance suggests for BellRing Brands (BRBR) BellRing Brands (BRBR) has seen its stock retreat recently, with a last close of $11.10 and negative returns over the past week, month, past 3 months, year to date, and past year. At the same time, the company reports annual revenue of $2.33b and net income of $158.2m. This reflects its position as a US-focused provider of ready to drink protein shakes, powders, and nutrition bars. See our latest analysis for BellRing...

Henry Schein (HSIC) is back in focus after reporting Q1 2026 results that topped analyst estimates, reaffirming 2026 guidance, and highlighting progress on value creation plans and ongoing share repurchases. See our latest analysis for Henry Schein. Despite better than expected Q1 results, reaffirmed 2026 guidance, and continued buybacks, Henry Schein’s short term share price performance has been weak, with a 30 day share price return of a 3.23% decline, while the 1 year total shareholder...

DENTSPLY SIRONA (XRAY) has opened 2026 with Q1 revenue of US$880 million and a basic EPS loss of US$0.05, alongside net income excluding extra items of a US$10 million loss, setting a cautious tone around current profitability. Over the past year, the company has seen quarterly revenue move between US$879 million and US$961 million, while basic EPS has ranged from a profit of US$0.10 to a loss of US$2.16. This underlines how volatile earnings have been even as the top line has stayed close to...

Eaton (NYSE:ETN) is back in focus after reporting record first quarter 2026 results, beating analyst expectations on sales and earnings while pairing that with more cautious guidance that prompted a pullback in the stock. See our latest analysis for Eaton. At a share price of $421.39, Eaton has seen strong short term momentum with a 15.8% 30 day share price return and a 28.74% year to date share price return, alongside a 40.66% 1 year total shareholder return, as investors weigh record...

Ingevity (NGVT) has drawn fresh attention after reporting first quarter 2026 results, with sales of US$258 million and net income of US$59.8 million, compared to US$247.9 million and US$20.5 million a year earlier. See our latest analysis for Ingevity. The earnings release appears to have been a key catalyst for the recent share price move, with a 10.49% 1 month share price return and a 29.59% year to date share price return. The 1 year total shareholder return of 98.5% points to strong...

Wondering whether Blue Owl Capital is attractively priced today, or if the recent excitement has already been baked into the stock. The share price closed at US$10.54, with recent returns of 18.7% over 7 days and 24.7% over 30 days, set against a year to date return of negative 31.2% and a 1 year return of negative 38.3%. These swings sit against a backdrop of ongoing interest in alternative asset managers and the broader capital markets sector. In this environment, investors often reassess...

Why American Tower’s latest quarter is drawing fresh attention American Tower (AMT) has moved into focus after first quarter earnings topped expectations, full year 2026 guidance was raised, and international operations such as Latin America and Europe featured prominently in management’s outlook. See our latest analysis for American Tower. That earnings beat and higher 2026 guidance have come alongside a 90 day share price return of 5.06% and a year to date share price return of 3.07%, even...

Investors may be wondering if Advanced Energy Industries at around US$360.81 is priced for perfection or still offers value, especially after such a strong run. The stock has been relatively steady over the last 7 days with a 0.2% decline. The 30 day return of 8.7% and 1 year return of 229.3% sit alongside multi year returns of 324.7% over 3 years and 315.6% over 5 years. Recent coverage has focused on Advanced Energy Industries as investors look at how its power conversion and control...

Marex Group (MRX) has opened 2026 with Q1 revenue of US$1.1b and basic EPS of US$1.57, alongside trailing twelve month EPS of US$4.65 and net income of US$333.9m, putting fresh numbers in front of investors watching its recent earnings momentum. Over the past year, the company has seen revenue move from US$2.36b to US$3.27b and EPS lift from US$2.96 to US$4.65 on a trailing basis, setting a clear context for how the latest quarterly print fits into the broader trend. Taken together with the...

Ardent Health Q1 2026 Earnings Snapshot Ardent Health (ARDT) opened 2026 with Q1 revenue of US$1.6 billion and basic EPS of US$0.28, providing a steady backdrop for investors watching how the business is progressing through the year. The company reported quarterly revenue of US$1.50 billion in Q1 2025 and around US$1.6 billion in Q1 2026, while basic EPS over that span moved from US$0.30 a year ago to US$0.28 this quarter. This frames a picture in which revenue growth appears to be coming...

Dutch Bros (BROS) caught investors attention after reporting first quarter 2026 revenue of US$464.41 million, up 31% year over year, and lifting full year guidance for revenue, earnings and planned store openings. See our latest analysis for Dutch Bros. The stock’s recent rally has picked up again, with a 12.67% 90 day share price return and a 3 year total shareholder return of about 2x, even though the year to date share price return is still slightly negative. If Dutch Bros’ earnings beat...

Callaway Golf Company recently confirmed it will release its Q1 2026 results and hold its earnings call on May 7, 2026, after the US market close, following a quarter in which it missed revenue expectations and lowered full-year guidance. This upcoming report has drawn attention because analysts are looking for year-on-year revenue growth after last year's decline, making it a key moment to reassess the strength of Callaway's recovery story. With analysts expecting Q1 revenue growth after...

DaVita (DVA) opened 2026 with Q1 revenue of US$3.4b and basic EPS of US$2.93, setting the tone for how its dialysis network is converting patient volumes into earnings. Over the past five quarters, the company has seen revenue move from US$3.2b in Q1 2025 to US$3.4b in Q1 2026, while quarterly EPS has ranged from US$2.05 to US$3.18, giving a clearer view of how throughput and cost control have translated into bottom line results. With trailing 12 month net profit margins at 5.5% versus 6.6% a...